Monte Rosa Therapeutics Inc (GLUE)
4.985
-0.24
(-4.50%)
USD |
NASDAQ |
May 20, 13:03
Monte Rosa Therapeutics Debt to Equity Ratio: 0.00 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2024 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Mar 2024
--
Maximum
Mar 2024
--
Average
--
Median
Mar 2024
Debt to Equity Ratio Benchmarks
Biogen Inc | 0.4299 |
Ionis Pharmaceuticals Inc | 4.301 |
CEL-SCI Corp | -- |
AIM ImmunoTech Inc | 0.00 |
IGC Pharma Inc | 0.0152 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 266.75M |
Total Liabilities (Quarterly) | 114.23M |
Shareholders Equity (Quarterly) | 152.52M |
Current Ratio | 4.820 |